Literature DB >> 23969601

CD97 is a multifunctional leukocyte receptor with distinct roles in human cancers (Review).

Michael Safaee1, Aaron J Clark, Michael E Ivan, Michael C Oh, Orin Bloch, Matthew Z Sun, Taemin Oh, Andrew T Parsa.   

Abstract

G-protein coupled receptors (GPCRs) represent the most diverse and biologically ubiquitous protein receptors. The epidermal growth factor seven-span transmembrane (EGF-TM7) family consists of adhesion GPCRs with a diverse functional repertoire. CD97 is the most broadly expressed member with roles in cell adhesion, migration and regulation of intercellular junctions. CD97 is also expressed in a variety of human malignancies including those of the thyroid, stomach, colon and brain. CD97 confers an invasive phenotype and has been shown to correlate with tumor grade, lymph node invasion, metastatic spread and overall prognosis. More recently, CD97 was found to signal through Gα12/13, resulting in increased RHO-GTP levels. Proven roles in tumor invasion and signaling make CD97 an exciting novel therapeutic target. In this review, we will discuss the structure and function of this receptor, with a specific focus on its mechanistic significance in neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23969601     DOI: 10.3892/ijo.2013.2075

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  19 in total

Review 1.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

2.  Habitual aerobic exercise and circulating proteomic patterns in healthy adults: relation to indicators of healthspan.

Authors:  Jessica R Santos-Parker; Keli S Santos-Parker; Matthew B McQueen; Christopher R Martens; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2018-09-20

Review 3.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

4.  Natural hybridization reveals incompatible alleles that cause melanoma in swordtail fish.

Authors:  Daniel L Powell; Mateo García-Olazábal; Mackenzie Keegan; Patrick Reilly; Kang Du; Alejandra P Díaz-Loyo; Shreya Banerjee; Danielle Blakkan; David Reich; Peter Andolfatto; Gil G Rosenthal; Manfred Schartl; Molly Schumer
Journal:  Science       Date:  2020-05-15       Impact factor: 47.728

5.  Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration.

Authors:  Yvona Ward; Ross Lake; Farhoud Faraji; Jamie Sperger; Philip Martin; Cameron Gilliard; Kimberly P Ku; Tamara Rodems; David Niles; Heather Tillman; JuanJuan Yin; Kent Hunter; Adam G Sowalsky; Joshua Lang; Kathleen Kelly
Journal:  Cell Rep       Date:  2018-04-17       Impact factor: 9.423

6.  Effects of targeted CD97 immune epitopes small interference RNA on cellular biological behaviors in MDA-MB231 malignant breast cancer cell line.

Authors:  Hua Tian; Yang Chen; Jian-Gang Zhao; Da-Ren Liu; Wei-Hua Gong; Li Chen; Yu-Lian Wu; Jian-An Wang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

7.  Phage display discovery of novel molecular targets in glioblastoma-initiating cells.

Authors:  J K Liu; D Lubelski; D L Schonberg; Q Wu; J S Hale; W A Flavahan; E E Mulkearns-Hubert; J Man; A B Hjelmeland; J Yu; J D Lathia; J N Rich
Journal:  Cell Death Differ       Date:  2014-05-16       Impact factor: 15.828

8.  Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood.

Authors:  John F Bowyer; Karen M Tranter; Joseph P Hanig; Nathaniel M Crabtree; Robert P Schleimer; Nysia I George
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

9.  Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia.

Authors:  Manja Wobus; Martin Bornhäuser; Angela Jacobi; Martin Kräter; Oliver Otto; Claudia Ortlepp; Jochen Guck; Gerhard Ehninger; Christian Thiede; Uta Oelschlägel
Journal:  Oncotarget       Date:  2015-11-17

10.  Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.

Authors:  Chiung-Kuei Huang; Yoshifumi Iwagami; Arihiro Aihara; Waihong Chung; Suzanne de la Monte; John-Michael Thomas; Mark Olsen; Rolf Carlson; Tunan Yu; Xiaoqun Dong; Jack Wands
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.